emerging technologies

Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.

Acting assistant under secretary for health at the U.S. Department of Veterans Affairs at the U.S. Department of Veterans Affairs, Dr. Mark Zhang, discusses the VA's research into 3D-printed biological material for veterans.

Pro Rodeo Hall of Fame roping champion Stran Smith discusses how he discovered he had a hole in his heart and how his journey to finding treatment allowed him to return to roping and continue both his career and his lifestyle.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.

Anne Osdoit, CEO of Moon Surgical, says the company’s robotic surgery offering serves as a surgical assistant in laparoscopic soft tissue procedures, using robotic arms to hold instruments and AI to give insights into workflow efficiency.

Nissan Elimelech, founder of Augmedics, shares how the company's augmented reality surgical technology projects an anatomically accurate 3D spine onto the patient, helping surgeons operate with their eyes on the body instead of a screen.  

Paul Grand, CEO of MedTech Innovator, discusses how the accelerator embraces high-risk, high-reward technologies and steers them to market with industry expertise.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.